Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation

Molecules and Cells

Volumn 31, Issue 4, 2011, Pages 371-377

  Kim, Seung Jin ^a   Choi, Hojung ^a   Park, Sung Soo ^a   Chang, Chawnshang ^b,c   Kim, Eungseok ^a  

^a Chonnam National University   (South Korea)

^b George Whipple Laboratory for Cancer Research   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Androgen receptor; CoRNR box; Prostate cancer; PSA; SCD

Indexed keywords

ACYL COENZYME A DESATURASE; ALANINE; ANDROGEN RECEPTOR; ANDROSTANOLONE; KALLIKREIN; KALLIKREIN RELATED PEPTIDASE 2; LEUCINE; MICRORNA; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; GENE SILENCING; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; TRANSACTIVATION; TRANSCRIPTION INITIATION; TUMOR GROWTH;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA INTERFERENCE; SEQUENCE ALIGNMENT; STEAROYL-COA DESATURASE; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR BURDEN; UP-REGULATION;

MUS MUSCULUS;

EID: 79959977655     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-011-0043-5     Document Type: Article

References (33)

1. Askari, B., Carroll, M.A., Capparelli, M., Kramer, F., Gerrity, R.G., and Bornfeldt, K.E. (2002). Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-I through a phospholipase D-dependent pathway in arterial smooth muscle cells. J. Biol. Chem. 277, 36338-36344.
2. Brinkmann, A.O., and Trapman, J. (2000). Prostate cancer schemes for androgen escape. Nat. Med. 6, 628-629. (Pubitemid 30398780)
3. Carascossa, S., Gobinet, J., Georget, V., Lucas, A., Badia, E., Castet, A., White, R., Nicolas, J.C., Cavailles, V., and Jalaguier, S. (2006). Receptor-interacting protein 140 is a repressor of the androgen receptor activity. Mol. Endocrinol. 20, 1506-1518. (Pubitemid 43967560)
4. Chang, C., Norris, J.D., Gron, H., Paige, L.A., Hamilton, P.T., Kenan, D.J., Fowlkes, D., and McDonnell, D.P. (1999). Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta. Mol. Cell. Biol. 19, 8226-8239. (Pubitemid 30414017)
5. Chawla, A., Repa, J.J., Evans, R.M., and Mangelsdorf, D.J. (2001). Nuclear receptors and lipid physiology: Opening the X-files. Science 294, 1866-1870. (Pubitemid 33101573)
6. Chen, Y., Kerimo, A., Khan, S., and Wei, L.N. (2002). Real-time analysis of molecular interaction of retinoid receptors and receptor-interacting protein 140 (RIP140). Mol. Endocrinol. 16, 2528-2537. (Pubitemid 35266071)
7. Culig, Z., Comuzzi, B., Steiner, H., Bartsch, G., and Hobisch, A. (2004). Expression and function of androgen receptor coacti-vators in prostate cancer. J. Steroid. Biochem. Mol. Biol. 92, 265-271. (Pubitemid 40128247)
8. Enoch, H.G., Catala, A., and Strittmatter, P. (1976). Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid. J. Biol. Chem. 251, 5095-5103.
9. Fritz, V., Benfodda, Z., Rodier, G., Henriquet, C., Iborra, F., Avances, C., Allory, Y., de la Taille, A., Culine, S., Blancou, H., et al. (2010). Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol. Cancer Ther. 9, 1740-1754.
10. Gerbod-Giannone, M.C., Del Castillo-Olivares, A., Janciauskiene, S., Gil, G., and Hylemon, P.B. (2002). Suppression of cholesterol 7alpha-hydroxylase transcription and bile acid synthesis by an alpha1-antitrypsin peptide via interaction with alpha1-fetoprotein transcription factor. J. Biol. Chem. 277, 42973-42980. (Pubitemid 35285676)
11. He, B., Minges, J.T., Lee, L.W., and Wilson, E.M. (2002). The FXXLF motif mediates androgen receptor-specific interactions with coregulators. J. Biol. Chem. 277, 10226-10235. (Pubitemid 34968137)
12. He, B., Gampe, R.T., Jr., Kole, A.J., Hnat, A.T., Stanley, T.B., An, G., Stewart, E.L., Kalman, R.I., Minges, J.T., and Wilson, E.M. (2004). Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol. Cell 16, 425-438. (Pubitemid 39504796)
13. Heinemann, F.S., Korza, G., and Ozols, J. (2003). A plasminogen-like protein selectively degrades stearoyl-CoA desaturase in liver microsomes. J. Biol. Chem. 278, 42966-42975. (Pubitemid 37345909)
14. Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Strom, A., Treuter, E., Warner, M., et al. (2007). Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 87, 905-931. (Pubitemid 47084672)
15. Hodgson, M.C., Shen, H.C., Hollenberg, A.N., and Balk, S.P. (2008). Structural basis for nuclear receptor corepressor recruit-ment by antagonist-liganded androgen receptor. Mol. Cancer Ther. 7, 3187-3194.
16. Hu, X., and Lazar, M.A. (1999). The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402, 93-96.
17. Hu, Y.C., Yeh, S., Yeh, S.D., Sampson, E.R., Huang, J., Li, P., Hsu, C.L., Ting, H.J., Lin, H.K., Wang, L., et al. (2004). Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. J. Biol. Chem. 279, 33438-33446. (Pubitemid 39062993)
18. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J.Q., and Thun, M.J. (2007). Cancer statistics, 2007. CA Cancer J. Clin. 57, 43-66. (Pubitemid 46148091)
19. Kim, E., Ma, W.L., Lin, D.L., Inui, S., Chen, Y.L., and Chang, C. (2007). TR4 orphan nuclear receptor functions as an apoptosis modulator via regulation of Bcl-2 gene expression. Biochem. Biophys. Res. Commun. 361, 323-328. (Pubitemid 47187262)
20. Leitzmann, M.F. (2005). Is there a link between macronutrient intake and prostate cancer? Nat. Clin. Pract. Oncol. 2, 184-185. (Pubitemid 40812463)
21. Lu, G., Morinelli, T.A., Meier, K.E., Rosenzweig, S.A., and Egan, B.M. (1996). Oleic acid-induced mitogenic signaling in vascular smooth muscle cells. A role for protein kinase C. Circ. Res. 79, 611-618. (Pubitemid 26276921)
22. Man, W.C., Miyazaki, M., Chu, K., and Ntambi, J.M. (2006). Membrane topology of mouse stearoyl-CoA desaturase 1. J. Biol. Chem. 281, 1251-1260.
23. Menendez, J.A., and Lupu, R. (2007). Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7, 763-777. (Pubitemid 47469806)
24. Mziaut, H., Korza, G., and Ozols, J. (2000). The N terminus of microsomal delta 9 stearoyl-CoA desaturase contains the sequence determinant for its rapid degradation. Proc. Natl. Acad. Sci. USA 97, 8883-8888. (Pubitemid 30626642)
25. Niu, Y.J., Yeh, S.Y., Miyamoto, H., Li, G.H., Altuwaijri, S., Yuan, J.Q., Han, R.F., Ma, T.X., Kuo, H.C., and Chang, C.S. (2008). Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation. Cancer Res. 68, 7110-7119.
26. Paine, E., Palmantier, R., Akiyama, S.K., Olden, K., and Roberts, J.D. (2000). Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein kinase 2 and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway. J. Biol. Chem. 275, 11284-11290. (Pubitemid 30212776)
27. Park, S.S., Choi, H., Kim, S.J., Kim, O.J., Chae, K.S., and Kim, E. (2008). FXR alpha down-regulates LXR alpha signaling at the CETP promoter via a common element. Mol. Cells 26, 409-414.
28. Scaglia, N., and Igal, R.A. (2005). Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells. J. Biol. Chem. 280, 25339-25349. (Pubitemid 40962236)
29. Suzuki, H., Ueda, T., Ichikawa, T., and Ito, H. (2003). Androgen receptor involvement in the progression of prostate cancer. Endocr. Relat. Cancer 10, 209-216. (Pubitemid 36758650)
30. Thin, T.H., Wang, L., Kim, E., Collins, L.L., Basavappa, R., and Chang, C. (2003). Isolation and characterization of androgen receptor mutant, AR(M749L), with hypersensitivity to 17-beta estradiol treatment. J. Biol. Chem. 278, 7699-7708. (Pubitemid 36800780)
31. Torosian, M.H., and Donoway, R.B. (1991). Growth hormone inhibits tumor metastasis. Cancer 67, 2280-2283.
32. Werz, O., Szellas, D., Steinhilber, D., and Radmark, O. (2002). Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2). J. Biol. Chem. 277, 14793-14800. (Pubitemid 34959961)
33. Yeh, S., Lin, H.K., Kang, H.Y., Thin, T.H., Lin, M.F., and Chang, C. (1999). From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc. Natl. Acad. Sci. USA 96, 5458-5463. (Pubitemid 29234639)